Research Publications

The Westmead Breast Cancer Institute has an established track record of research with over 200 publications in peer reviewed journals, conference abstracts and book chapters. 

Current publication search:

   RSS: NSW Breast Cancer Institute.

   RSS: Boyages, J.

2010

Sherman, K. Heard, G. Cavanagh, K. Psychological effects and mediators of a group exercise and informational support program for breast cancer survivors. Journal of Behavioural Medicine, 27 May, 2010. DOI 10.1007/s10865-010-9265-9

Roussi P, Sherman KA, Miller S, Buzaglo J, Daly M, Taylor A, et al. Enhanced counselling for women undergoing BRCA1/2 testing: impact on knowledge and psychological distress - results from a randomised clinical trial. Psychology & Health. 2010 Apr 2010;25(4):401-15.

Sherman KA, Kasparian NA, Mireskandari S. Psychological adjustment among male partners in response to women's breast/ovarian cancer risk: a theoretical review of the literature. Psychooncology. In Press Jan;19(1):1-11, 2009. 

Sherman KA, Koelmeyer L. The role of lymphedema information sources and objective risk status on knowledge and practice of lymphedema risk minimization behaviors among women recently diagnosed with breast cancer. Oncology Nursing Forum. In Press Accepted 21st December, 2009.

Watts KJ, Sherman KA, Mireskandari S, Meiser B, Taylor A, Tucker T. Predictors of relationship adjustment among couples coping with a high risk of developing breast/ovarian cancer. Psychology & Health. In Press accepted 4 January, 2010.

2009

Coombs NJ, Cronin KA, Taylor RJ, Freedman AN, Boyages J. The impact of changes in hormone therapy on breast cancer incidence in the US population. Cancer Causes Control 2009 Oct 1.

Smith MJ, Gill PG, Wetzig N, Sourjina T, Gebski V, Ung O, et al. Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial). Breast Cancer Res Treat 2009 Sep;117(1):99-109.

Coombs NJ, Boyages J, French JR, Ung OA. Internal mammary sentinel nodes: ignore, irradiate or operate? Eur J Cancer 2009 Mar;45(5):789-94.

Roussi P, Sherman KA, Miller S, Buzaglo J, Daly M, Taylor A, et al. Enhanced counselling for women undergoing BRCA1/2 testing: impact on knowledge and psychological distress - results from a randomised clinical trial. Psychology & Health. 2009 Feb 3:1-15.

Jayasinghe UW, Boyages J. Tumour location is not an independent prognostic factor for survival following a diagnosis of breast cancer. Breast 2009 Feb;18(1):41-6.

2008

Coombs NJ, Boyages J, French JR, Ung OA. Internal mammary sentinel nodes: Ignore, irradiate or operate? Eur J Cancer 2008 Dec 31.

Jayasinghe UW, Boyages J. Tumour location is not an independent prognostic factor for survival following a diagnosis of breast cancer. Breast 2008 Nov 21.

Sheehan J, Sherman KA, Lam T, Boyages J. Association of information satisfaction, psychological distress and monitoring coping style with post-decision regret following breast reconstruction. Psycho-Oncology 2008.

Ung OA. Breast surgical oncology and aesthetics. ANZ J Surg 2008 Apr;78(4):225-6.

Sheehan J, Sherman KA, Lam T, Boyages J. Regret associated with the decision for breast reconstruction: The association of negative body image, distress and surgery characteristics with decision regret. Psychology & Health. 2008 Feb;23(2):207-19.

2007

Ahern V, Boyages J, Gebski V, Moon D, Wilcken N. Selective mastectomy in the management of locally advanced breast cancer. Int J Radiat Oncol Biol Phys 2007 Jul 15;68(4):1010-7.

Ahern V, Boyages J, Gebski V, Moon D, Wilcken N. Selective mastectomy in the management of locally advanced breast cancer. Int J Radiat Oncol Biol Phys 2007 Jul 15;68(4):1010-7.

Cheung NW, Lou JC, Boyages SC. Growth hormone does not increase thyroid size in the absence of TSH: A study in adults with hypopituitarism. J Clin Endorinol Metab 2007.

Coombs N, Chen W, Taylor R, Boyages J. A decision tool for predicting sentinel node accuracy from breast tumor size and grade. Breast J 2007 Nov;13(6):593-8.

Houssami N, Boyages J, Stuart K, Brennan M. Quality of breast imaging reports falls short of recommended standards. Breast 2007 Jun;16(3):271-9.

Jayasinghe UW, Bilous AM, Boyages J. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma? Breast J 2007 Sep;13(5):479-85.

Mireskandari S, Sherman KA, Meiser B, Taylor AJ, Gleeson M, Andrews L, et al. Psychological adjustment among partners of women at high risk of developing breast/ovarian cancer. Genetics in Medicine. 2007 May;9(5):311-20.

Sheehan J, Sherman KA, Lam T, Boyages J. Association of information satisfaction, psychological distress and monitoring coping style with post-decision regret following breast reconstruction. Psychooncology. 2007 Apr;16(4):342-51.

 

Tan MP, Ung OA. Surgical approach to the angular vein of the axilla: an ''inverted'' technique of axillary dissection. Breast J 2007 Mar;13(2):220-2.

2006

Boyages J, Taylor R, Chua B, Ung O, Bilous M, Salisbury E, et al. A risk index for early node-negative breast cancer. Br J Surg 2006 May;93(5):564-71.

Boyages J, Connolly JL, Schnitt SJ. Definitions of an extensive intraductal component. Australian Cancer Network Working Party The Pathology Reporting of Breast Cancer: A Guide for Pathologists, Surgeons and Radiologists 2006;66-76.

Boyages J, Taylor R, Chua B, Ung O, Bilous M, Salisbury E, et al. A risk index for early node-negative breast cancer. Br J Surg 2006 May;93(5):564-71.

Brennan M, Black E, French J, Boyages J. Breast cancer--guiding your patient through treatment. Aust Fam Physician 2006 Mar;35(3):117-20.

Coombs NJ, Boyages J. Changes in HRT prescriptions dispensed in Australia since 1992. Aust Fam Phys 2006.

Ha TC, Lyons-Wall PM, Moore DE, Tattam BN, Boyages J, Ung OA, et al. Phytoestrogens and indicators of breast cancer prognosis. Nutr Cancer 2006;56(1):3-10.

Laura S, Coombs NJ, Ung O, Boyages J. Tumour size as a predictor of axillary node metastases in patients with breast cancer. ANZ J Surg 2006 Nov;76(11):1002-6.

Stuart K, Brennan M, French J, Houssami N, Boyages J. Life after breast cancer. Aust Fam Physician 2006 Apr;35(4):219-24.

Taylor R, Jayasinghe UW, Koelmeyer L, Ung O, Boyages J. Reliability and validity of arm volume measurements for assessment of lymphedema. Phys Ther 2006 Feb;86(2):205-14.

Ung O, Tan M, Chua B, Barraclough B. Complete axillary dissection: a technique that still has relevance in contemporary management of breast cancer. ANZ J Surg 2006 Jun;76(6):518-21.

Mireskandari S, Meiser B, Sherman K, Warner BJ, Andrews L, Tucker KM. Evaluation of the needs and concerns of partners of women at high risk of developing breast/ovarian cancer. Psychooncology. 2006 Feb;15(2):96-108.

Kirk J, Brennan M, Houssami N, Ung O. An approach to the patient with a family history of breast cancer. Aust Fam Physician 2006 Jan;35(1-2):43-7.

2005

Bilous M, Brennan M, French J, Boyages J. Making sense of breast pathology. Aust Fam Physician 2005 Jul;34(7):581-6.

Brennan M, French J, Houssami N, Kirk J, Boyages J. Breast cancer in young women. Aust Fam Physician 2005 Oct;34(10):851-5.

Brennan M, Wilcken N, French J, Ung O, Boyages J. Management of early breast cancer--the current approach. Aust Fam Physician 2005 Sep;34(9):755-60.

Brennan M, French J, Houssami N, Kirk J, Boyages J. Breast cancer in young women. Aust Fam Physician 2005 Oct;34(10):851-5.

Miller SM, Roussi P, Daly MB, Buzaglo JS, Sherman K, Godwin AK, et al. Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors. Health Educ Behav. 2005 Oct;32(5):654-67.

Brennan M, Wilcken N, French J, Ung O, Boyages J. Management of early breast cancer--the current approach. Aust Fam Physician 2005 Sep;34(9):755-60.

Coombs NJ, Taylor R, Wilcken N, Fiorica J, Boyages J. Hormone replacement therapy and breast cancer risk in California. Breast J 2005 Nov;11(6):410-5.

Coombs NJ, Boyages J. Multifocal and multicentric breast cancer: does each focus matter? J Clin Oncol 2005 Oct 20;23(30):7497-502.

Coombs NJ, Boyages J. Changes in HT prescriptions in Australia since 1992. Aust Fam Physician 2005 Aug;34(8):697-8.

Coombs NJ, Taylor R, Wilcken N, Boyages J. HRT and breast cancer: impact on population risk and incidence. Eur J Cancer 2005 Aug;41(12):1775-81.

Coombs NJ, Taylor R, Wilcken N, Boyages J. Hormone replacement therapy and breast cancer: estimate of risk. BMJ 2005 Aug 6;331(7512):347-9.

Coombs NJ, Taylor R, Wilcken N, Fiorica J, Boyages J. Hormone replacement therapy and breast cancer risk in California. Breast J 2005 Nov;11(6):410-5.

Coombs NJ, Boyages J. Multifocal and multicentric breast cancer: does each focus matter? J Clin Oncol 2005 Oct 20;23(30):7497-502.

Coombs NJ, Taylor R, Wilcken N, Boyages J. HRT and breast cancer: impact on population risk and incidence. Eur J Cancer 2005 Aug;41(12):1775-81.

Coombs NJ, Taylor R, Wilcken N, Boyages J. Hormone replacement therapy and breast cancer: estimate of risk. BMJ 2005 Aug 6;331(7512):347-9.

Coombs NJ, Boyages J. Changes in HT prescriptions in Australia since 1992. Aust Fam Physician 2005 Aug;34(8):697-8.

Jayasinghe UW, Taylor R, Boyages J. Is age at diagnosis an independent prognostic factor for survival following breast cancer? ANZ J Surg 2005 Sep;75(9):762-7.

Stuart K, Boyages J, Brennan M, Ung O. Ductal carcinoma in situ--management update. Aust Fam Physician 2005 Nov;34(11):949-54.

Houssami N, Irwig L, Ung O. Review of complex breast cysts: implications for cancer detection and clinical practice. ANZ J Surg 2005 Dec;75(12):1080-5.

Ahern V, Brennan M, Ung O, Kefford R. Locally advanced and inflammatory breast cancer. Aust Fam Physician 2005 Dec;34(12):1027-32.

Houssami N, French J, Brennan M, Ahern V, Ung O. Breast cancer--new and emerging technologies for diagnosis and management. Aust Fam Physician 2005 Aug;34(8):657-61.

Wetzig NR, Gill PG, Ung O, Collins J, Kollias J, Gillett D, et al. Participation in the RACS sentinel node biopsy versus axillary clearance trial. ANZ J Surg 2005 Mar;75(3):98-100.

2004

Leong C, Boyages J, Jayasinghe U, Bilous M, Salisbury E, Wong A, Ung O, Chua B. The effect of ipsilateral breast tumor recurrence after breast conservation therapy for node-negative breast cancer. Cancer 2004; 100: 1823-1832.

Lord S, Ghersi D, Gattellari M, Wortley S, Wilcken N, Simes J. Antitumour antibiotic containing regimens for metastatic breast cancer. Cochrane Database of Systematic Reviews 2004; (4): CD003367.

Nowak A, Wilcken N, Stockler M, Hamilton A, Ghersi D. Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer. The Lancet Oncology 2004; 5:372-380.

Ung OA (on behalf of the SNAC Trial Management, and Safety and Data Monitoring Committees). Australasian experience and trials in sentinel lymph node biopsy: the RACS SNAC trial. Asian Journal of Surgery 2004; 27: 284-290.

White V, Pruden M, Giles G, Collins J, Jamrozik K, Inglis G, Boyages J, Hill D. The management of early breast carcinomna before and after the introduction of clinical practice guidelines. Cancer 2004; 101: 476-485.

Wilcken N, Endocrine therapy for metastatic breast cancer – where we’re up to. Progress in Palliative Care 2004; 12: 67–70.

Boyages J, Jayasinghe U, Heard G, O’Connell D, Taylor R. The management of breast cancer in New South Wales in 1995. Sydney: NSW Breast Cancer Institute and The Cancer Council NSW, 2004.

Carrick S, Ghersi D, Wilcken N, Simes J. Platinum containing regimens for metastatic breast cancer. Cochrane Database of Systematic Reviews 2004; (3): CD003374.

Beslija S, Bonneterre J, Burstein HJ, Gnant M, Goodwin P, Heinemann V, Jassem J, Kostler W, Krainer M, Menard S, Miles D, Petruzelka L, Possinger K, Schmid P, Stadtmauer E, Stockler M, Van Belle S, Vogel C, Wilcken N, Wiltschke C, Zielinski CC, Zwierzina H. Consensus on medical treatment of metastatic breast cancer (statement for Central European Cooperative Oncology Group). Breast Cancer Research and Treatment 2003; 81: S1–S7.

Boyages J. Breast self-examination: be alert but not alarmed? Medical Journal of Australia 2003; 179: 456.

Chua B, Ung O, Taylor R, Boyages J. Is information from axillary Dissection relevant to patients with clinically node-negative breast cancer? The Breast Journal 2003; 9(6): 478-484.

Chua B, Ung O, Taylor R, Boyages J. Has information from axillary dissection become irrelevant in treatment selection for patients with clinically node-negative breast cancer? The Breast Journal 2003; 9: 478–484.

Ghersi D, Wilcken N, Simes J, Donoghue E. Taxanes for metastatic breast cancer [Cochrane review]. Cochrane Database of Systematic Reviews 2003; CD003366.

Houssami N, Irwig L, Simpson JM, McKessar M, Blome S, Noakes J. Sydney breast imaging accuracy study: comparative sensitivity and specificity of mammography and sonography in young women with symptoms. AJR 2003; 180: 935-940.

Houssami N, Irwig L, Simpson JM, McKessar M, Blome S, Noakes J. The contribution of work-up or additional views to the accuracy of diagnostic mammography. The Breast 2003; 12: 270-275.

Lam TC, Sellars GD. Free perforator crossover TRAM flap for breast reconstruction. Annals of Plastic Surgery 2003; 50: 126–131.

Stockler M, Wilcken N, Coates A. Chemotherapy for advanced breast cancer – how long should it continue? Breast Cancer Research and Treatment 2003; 81: S49–S52.

Taylor R, Davis P, Boyages J. Long-term survival with breast cancer in New South Wales women. European Journal of Cancer 2003; 39: 215–222.

Wilcken N, Hornbuckle J, Ghersi D. Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer [Cochrane review]. Cochrane Database of Systematic Reviews 2003; CD002747.

Wilcken N. The management of metastatic breast cancer. In Williams C, ed. Evidence-based oncology. London: BMJ Books, 2003.

Wilcken N. Breast cancer screening, IARC report [book review]. The Lancet Oncology 2003, 4: 192–193.

Wilcken N. Treatment of cancer, eds Price and Sikora [book review]. Progress in Palliative Care 2003, March.

Wilcken N. HERA – new lessons from a new trial. Cancer Forum 2003; 27: 8.

Wilcken N. Periodic funny turns. The Lancet Oncology 2003; 3: 772–773.

Wilcken NRC, Stockler MR. Fulvestrant: spreading the word, but not too thinly. The Lancet 2003; 362: 1254.

Wilcken N, Hornbuckle J, Ghersi D. Chemotherapy or endocrine therapy for metastatic breast cancer? Breast Cancer Research and Treatment 2003; 81: S53–S56.

Duric V, Sharpe L, Stockler M, Butow P, Dhillon H, Boyle F, Sullivan A, Beith J, Wilcken N. Psychosocial predictors of decisions about adjuvant chemotherapy (ACT) among women with early breast cancer (EBC). Psycho-Oncology 2003; 12: S194.

Duric V, Stockler M, Butow P, Sharpe L, Dhillon H, Boyle B, Sullivan A, Beith J, Wilcken N. What do patients and their partners think makes adjuvant chemotherapy (ACT) in early breast cancer (EBC) worthwhile? Psycho-Oncology 2003; 12: S264.

2002

Boyages J, Chua B, Taylor R, Bilous M, Salisbury E,Wilcken N, Ung O. Use of St Gallen classification for patients with node-negative breast cancer may lead to overuse of adjuvant chemotherapy. British Journal of Surgery 2002; 89: 789-796.

Chua B, Ung O, Boyages J. Competing considerations in nodal treatment for early breast cancer. The Breast Journal 2002; 8:15–22.

Chua B, Ung O, Taylor R, Boyages J. Is there a role for axillary clearance for patients with operable breast cancer in this era of conservatism? Australian and New Zealand Journal of Surgery 2002: 72 786–792.

De Morgan S, Redman S, White KJ, Cakir B, Boyages J. “Well, have I got cancer or haven’t I?” The psychosocial issues for women diagnosed with ductal carcinoma in situ. Health Expectations 2002; 5: 310–318.

Wilcken N. Mammography screening. The Lancet Oncology 2002; 3:268.

2001

Chua B, Ung O, Boyages J. Treatment of the Axilla in early breast cancer: past, present and future. Australian and New Zealand Journal of Surgery 2001; 71: 729–36.

Chua B, Ung O, Taylor R, Bilous M, Salisbury E, Boyages. Treatment implications of a positive sentinel lymph node biopsy in early breast cancer. Cancer 2001; 92: 1769–74.

Chua B, Ung O, Taylor R, Boyages J. Frequency and predictors of axillary lymph node metastases in early breast cancer. Australian and New Zealand Journal of Surgery 2002; 71: 723–28.

Grogan M, Rangan A, Gebski V, Boyages J. The value of follow-up of patients with early stage breast cancer who have been treated with conservative surgery and radiation therapy? The Breast 2001;11:163–169.

Grogan M, Tabar L, Chua B, Chen H-H, Boyages J. Estimating the benefits of adjuvant systemic therapy for women with early breast cancer. British Journal of Surgery 2001; 88: 1513–18.

Papadatos G, Rangan AM, Psarianos T, Ung O, Taylor R, Boyages J. Tubular carcinoma of the breast: probability of nodal involvement. British Journal of Surgery 2001; 88: 860–864.

Taylor R, Boyages J. Estimating absolute risk of breast cancer from population incidence affected by widespread mammographic screening. Journal of Medical Screening 2001; 8: 73–76.

Taylor R, Heard G, Boyages J. Estimating a woman’s risk of breast cancer: the effects of age and family history. Public Health Bulletin 2001: 12: 36–40.

Ung OA, Lee WB, Greenberg ML, Bilous M. complex sclerosing Lesion: the lesion is complex, the management is straightforward. Australian and New Zealand Journal of Surgery 2001; 71: 35–40.

2000

Boyages J, Rangan AM, Harris J. Overview. In Tepper: Clinical Radiation Oncology, part G, Breast cancer. New York: Churchill Livingstone, 2000, pp 958–968

Boyages J, Taylor R. Absolute risk of breast cancer for Australian women with a family history [article]. Australian and New Zealand Journal of Surgery 2000; 70: 725–731.

Boyages J, Ung OA. Authors’ reply [to van Langenburg’s comments on Francis et al. British Journal of Surgery 1999; 86: 1556–1562]. British Journal of Surgery 2000; 87: 681.

Delaney G, Beckham W, Veness M, Ahern V, Back M, Boyages J, Fox C, Graham P, Jacob G, Lonergan D, Morgan G, Pendlebury S, Yuile P. Three-dimensional dose distribution of tangential breast irradiation: results of a multicentre phantom dosimetry study. Radiotherapy and Oncology 2000; 57: 61–68.

Kenny P, King M, Shiell A, Seymour J, Hall J, Langlands A, Boyages J. Early breast cancer: costs and quality of life one year after treatment by mastectomy or conservative surgery and radiation therapy. The Breast 2000; 9: 37–44.

King M, Kenny P, Shiell A, Boyages J. Quality of life three months and one year after first treatment for early breast cancer: influence of treatment and patient characters. Quality of Life Research 2000; 9: 789–800.

Parr N, Boyages J, Taylor R, Anura P, Callaghan T. Projecting mammographic screens. Journal of Medical Screening 2000; 7: 146–151. Read abstract.

Rangan AM, Ahern V, Yip D, Boyages J. Local recurrence after mastectomy and adjuvant CMF: implications for adjuvant radiation therapy. Australian and New Zealand Journal of Surgery 2000; 70: 649–655.

Ung OA, Zorbas H. Managing mastalgia: fact or fiction? Current Therapeutics 2000; 4: 10–15.

1999

Boyages J. Making a decision about Breast conservation [invited opinion]. In Joss B. My left breast—how breast cancer transformed my life. Part 4, section 2. Sydney: Joss and Co., 1999, 116–117

Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment on ductal carcinoma in situ: a meta-analysis [article]. Cancer 1999; 85(3): 616–628.

Boyages J, Ung O. Breast cancer with extensive intraductal component [case study]. Case 3.3. In Harnett PR, Glare, Cartmill (Eds). Oncology, a case-based manual. Oxford University Press, 1999.

Francis M, Cakir B, Bilous M, Ung O, Boyages J. Conservative surgery and radiation therapy for invasive lobular Carcinoma of the breast [article]. Australian and New Zealand Journal of Surgery 1999; 69: 450–454.

Francis M, Cakir B, Ung O, Gebski V, Boyages J. Prognosis after local recurrence following conservative surgery and radiotherapy in node-negative breast cancer [article]. The British Journal of Surgery 1999; 86: 1556–1562.

Hill D, Jamrozik K, White V, Collins J, Boyages J, Shugg D, Pruden M, Giles G, Byrne M. Surgical management of breast cancer in Australia in 1995. Sydney: NHMRC National Breast Cacner Centre, 1999.

Langlands AO, Ahern V, Ung O, Boyages J. The management of high-risk node-positive breast cancer by standard-dose chemotherapy and loco-regional radiotherapy [article]. The Breast 1999; 8: 195–199.

Newman P, Bilous M, Boyages J. Is centralised histopathology review necessary for screen-detected breast lesions? [article] The Breast 1999; 8: 320–327.

Rangan A, Stubbs J. Discussing alternative therapies with your patients [article]. Australian Family Physician 1999; 28: 877–878.

Taylor R, Stubbs JM, Langlands AO, Boyages J. Predictors of mastectomy for women with breast cancer in the Greater Western Region of Sydney [article]. The Breast Journal 1999; 5:116–21.

Ung O. The Lumpectomy option [invited opinion]. In Joss B. My left breast—how breast cancer transformed my life. Part 4, section 2. Sydney: Joss and Co., 1999, 117–119.

Ung OA, Wetzig NR. Sentinel node Biopsy: evaluating a new technique [invited editorial]. Medical Journal of Australia 1999; 171: 452–453.

Warner NJ, King M, Langlands AO, Kenny P, Boyages J. Symptoms 2 weeks, 3 months and 12 months after treatment of early breast cancer: the patients’ perspectives [article]. The Breast 1999; 8: 273–277.

Wong SWJ, Rangan AM, Bilous M, Boyages J, Benson EM. The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting [article]. Pathology 1999; 31: 90–94.

Yip D, Rangan AM, Harnett PR, Ahern V, Boyages J. Adjuvant chemotherapy for node-positive breast cancer: a retrospective comparison of two different regimens of cyclophosphamide, methotrexate and 5-fluorouracil [article]. The Breast 1999; 8: 28–34.

1998

Connolly JL, Boyages J, Nixon AJ, Peiro G, Gage I., Silver B, Recht A, Harris JR, Schnitt SJ. Predictors of breast Recurrence after conservative surgery and radiation therapy for invasive breast cancer. Modern Pathology 1998; 11(2):134–9.

Boyages, J. and  Langlands, A.O.  Post-Mastectomy Radiation Therapy: Better Late than Never. Australian & New Zealand Journal of Surgery 1998 68:550-553

Gamble A, Gebski V, Boyages J. Solugel versus silver sulphadiazine cream in the treatment of radiation-induced moist Desquamation. Primary Intention 1998; 6(3): 102–107.

Gurney H, Harnett P, Kefford R, Boyages J. Inflammatory breast cancers: enhanced local control with hyperfractionated and infusional vincristine, ifosfamide and epirubicin [article]. Australian &New Zealand Journal of Medicine 1998; 28: 400–402.

Kerr C, Taylor R, Heard G, eds. Handbook of public health methods [book], Sydney: McGraw Hill Australia, 1998, 755 pp.

Langlands, A.O.  Breast cancer and malpractice litigation. [article]Medical Journal of Australia 1998; 169(4):212­214 ©Copyright The Medical Journal of Australia - reproduced with permission

Lazarus R, Heard G. Measurement of health status [unit and appendix]. In Kerr C, Taylor R, Heard G, eds, Handbook of public health methods, unit 8 & appendix 4, Sydney: McGraw Hill Australia, 1998, 48–51, 741–5.

McGeechan K, Kricker A, Armstrong B, Stubbs J. Evaluation of linked cancer registry and hospital records of breast cancer [article]. Australian and New Zealand Journal of Public Health  1998; 22: 765–70,.

Stubbs J, Boyages J. The Western Areas Breast Group health outcomes study [article]. Breast News 1998; 4(2): 4

Warner NJ, Rangan AM, Langlands AO, Boyages J. Effect of concurrent chemotherapy and radiotherapy on breast cosmesis: a study of patients’ perceptions [article]. The Breast 1998; 7: 131–6.

1997

Zissiadis, Y., Langlands, A. O., Barraclough, B. and Boyages, J.  Breast Conservation: Long-term results from Westmead Hospital. Australian & New Zealand Journal of Surgery.1997  67: 313-319.

Christie DRH, Kirk JA, Clarke CL, Boyages J. Association of hereditary angioedema and hereditary breast cancer. Cancer Genet Cytogenet 1997; 95: 159–162.

Delaney, G., Ung, O., Bilous, M., Cahill, S., Greenberg, M. and Boyages J.  Ductal Carcinoma In Situ Part 1: Definition and Diagnosis. Australian & New Zealand Journal of Surgery.1997 67: 81­93.

Delaney, G., Ung, O., Cahill, S., Bilous, M. and Boyages, J.  Ductal Carcinoma In Situ Part 2: Treatment. Australian & New Zealand Journal of Surgery 1997 67: 157-165.

Ward, J.E., Boyages, J. and Gupta, L.  Local Impact of the NHMRC early breast cancer guidelines: where to from here? MJA 1997; 167:362­365 ©Copyright 1997 The Medical Journal of Australia 1997- reproduced with permission.

1996

Barton M, Boyages J, Crennan E, Davis S, Fisher RJ, Hook C, Johnson N, Joseph D, Khoo V, et al. Radiotherapy for early infradiaphragmatic Hodgkin’s disease: the Australasian experience. Radiotherapy & Oncology 1996; 39:1–7.

1995

Ung O, Langlands AO, Barraclough B, Boyages J. Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement. J Clin Oncol 1995 Feb;13(2):435-43.

1994

Ahern V, Barraclough B, Bosch C, Langlands A, Boyages J. Locally advanced breast cancer: defining an optimum treatment regimen. Int J Radiat Oncol Biol Phys 1994 Mar 1;28(4):867-75.

Kodali S, Burkley M, Nag K, Taylor RC, Moudgil VK. Taxol and cisplatin inhibit proliferation of T47D human breast cancer cells. Biochem Biophys Res Commun 1994 Aug 15;202(3):1413-9.

Nakanishi H, Taylor RM, Hawkins AL, Griffin CA, Martin GR, Passaniti A. Establishment of hormone-dependent and hormone-independent carcinoma cell lines with different metastatic potentials from spontaneous mammary tumors in aged Wistar rats. Int J Cancer 1994 Aug 15;58(4):592-601.

1993

Graham P, Boyages J. Economic and quality-of-life aspects of treating small cell lung cancer. Pharmacoeconomics 1993 Jun;3(6):446-53.

Turner S, Marosszeky B, Timms I, Boyages J. Malignant spinal cord compression: a prospective evaluation. Int J Radiat Oncol Biol Phys 1993 Apr 30;26(1):141-6.

1992

Boyages J, Langlands AO. Breast cancer: the role of radiation therapy after treatment by conservative surgery. Aust N Z J Surg 1992 Jun;62(6):422-8.

Boyages J, Bosch C, Langlands AO, Bilous AM, Barraclough B, Gebski VJ. Breast conservation: long-term Australian data. Int J Radiat Oncol Biol Phys 1992;24(2):253-60.

Boyages J, Tiver KW. Adjuvant systemic therapy in breast cancer. Part 1: Adjuvant hormone therapy. Aust N Z J Surg 1992 May;62(5):354-63.

Lindeman GJ, Boyages J, Driessen C, Langlands AO. Intravenous or oral adjuvant CMF for node-positive breast cancer. Aust N Z J Surg 1992 Jul;62(7):556-62.

Vicini FA, Recht A, Abner A, Boyages J, Cady B, Connolly JL, et al. Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer. J Natl Cancer Inst Monogr 1992;(11):33-9.

1990

Boyages J, Recht A, Connolly JL, Schnitt SJ, Gelman R, Kooy H, et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 1990 Sep;19(1):29-41.

Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JH, Verbeek AL, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990 Jan;8(1):113-8.

1989

Boyages J, Recht A, Connolly J, Schnitt S, Rose MA, Silver B, et al. Factors associated with local recurrence as a first site of failure following the conservative treatment of early breast cancer. Recent Results Cancer Res 1989;115:92-102.

Boyages J, Harris JR. Local therapy of invasive disease. Hematol Oncol Clin North Am 1989 Dec;3(4):675-90.

Epstein AH, Connolly JL, Gelman R, Schnitt SJ, Silver B, Boyages J, et al. The predictors of distant relapse following conservative surgery and radiotherapy for early breast cancer are similar to those following mastectomy. Int J Radiat Oncol Biol Phys 1989 Oct;17(4):755-60.

Langlands AO, Boyages J. Adjuvant therapy for breast cancer. Aust N Z J Surg 1989 Oct;59(10):767-8.

Rose MA, Henderson IC, Gelman R, Boyages J, Gore SM, Come S, et al. Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure. Int J Radiat Oncol Biol Phys 1989 Oct;17(4):711-7.

1988

Boyages J, Bilous M, Barraclough B, Langlands AO. Fat necrosis of the breast following lumpectomy and radiation therapy for early breast cancer. Radiother Oncol 1988 Sep;13(1):69-74.

Boyages J, Barraclough B, Middledorp J, Gorman D, Langlands AO. Early breast cancer: cosmetic and functional results after treatment by conservative techniques. Aust N Z J Surg 1988 Feb;58(2):111-21.

Boyages J, Langlands AO. The efficacy of combined chemotherapy and radiotherapy in advanced non-metastatic breast cancer. Int J Radiat Oncol Biol Phys 1988 Jan;14(1):71-8.

Francis M, Cakir B, Ung O, Gebski V, Boyages J. Prognosis after breast recurrence following conservative surgery and radiotherapy in patients with node-negative breast cancer. Br J Surg 1999 Dec;86(12):1556-62.

Francis M, Cakir B, Bilous M, Ung O, Boyages J. Conservative surgery and radiation therapy for invasive lobular carcinoma of the breast. Aust N Z J Surg 1999 Jun;69(6):450-4.

Kari FW, Dunn SE, French JE, Barrett JC. Roles for insulin-like growth factor-1 in mediating the anti-carcinogenic effects of caloric restriction. J Nutr Health Aging 1999;3(2):92-101.

Langlands A, Ahern V, Ung O, Boyages J. Management of high-risk node-positive breast cancer by standard-dose chemotherapy and loco-regional radiotherapy. Breast 1999 Aug;8(4):195-9.

Newman P, Bilous M, Boyages J. Is centralized histopathology review necessary for screen-detected breast lesions? Breast 1999 Dec;8(6):320-7.

Stubbs J, Rangan A. Discussing alternative therapies with your patients. Aust Fam Physician 1999 Sep;28(9):877-8.

Taylor R, Stubbs JM, Langlands AO, Boyages J. Predictors of Mastectomy for Women with Breast Cancer in the Greater Western Region of Sydney. Breast J 1999 Mar;5(2):116-21.

Warner NJ, King M, Langlands AO, Kenny P, Boyages J. Symptoms 2 weeks, 3 months and 12 months after treatment of early breast cancer: the patients' perspectives. Breast 1999 Oct;8(5):273-7.

Wong SW, Rangan AM, Bilous AM, Boyages J, Gebski V, Benson EM. The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting. Pathology 1999 May;31(2):90-4.

1998

Boyages J, Langlands A. Postmastectomy radiation therapy: better late than never. Aust N Z J Surg 1998 Aug;68(8):550-3.

Connolly JL, Boyages J, Nixon AJ, Peiro G, Gage I, Silver B, et al. Predictors of breast recurrence after conservative surgery and radiation therapy for invasive breast cancer. Mod Pathol 1998 Feb;11(2):134-9.

Gurney H, Harnett P, Kefford R, Boyages J. Inflammatory breast cancer: enhanced local control with hyperfractionated radiotherapy and infusional vincristine, ifosfamide and epirubicin. Aust N Z J Med 1998 Jun;28(3):400-2.

Langlands AO. Breast cancer and malpractice litigation. Med J Aust 1998 Aug 17;169(4):212-4.

Poola I, Williams DM, Koduri S, Ramprakash J, Taylor RE, Hankins WD. Quantitation of estrogen receptor mRNA copy numbers in breast cancer cell lines and tumors. Anal Biochem 1998 May 1;258(2):209-15.

Rickard MT, Taylor RJ, Fazli MA, El HN. Interval breast cancers in an Australian mammographic screening program. Med J Aust 1998 Aug 17;169(4):184-7.

1986

Boyages J. The problem of local control in patients with advance breast cancer--a combined modality approach. Australas Radiol 1986 Feb;30(1):60-2.

1985

Bottles K, Taylor RN. Diagnosis of breast masses in pregnant and lactating women by aspiration cytology. Obstet Gynecol 1985 Sep;66(3 Suppl):76S-8S.

1983

Taylor R, Parker M, Ansford A, Davison A. Cancer in Solomon Islands 1970-82. P N G Med J 1983 Jun;26(2):102-10.

1982

Roses DF, Bell DA, Flotte TJ, Taylor R, Ratech H, Dubin N. Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancer. Am J Clin Pathol 1982 Dec;78(6):817-20.

Taylor RE, Powles TJ, Humphreys J, Bettelheim R, Dowsett M, Casey AJ, et al. Effects of endocrine therapy on steroid-receptor content of breast cancer. Br J Cancer 1982 Jan;45(1):80-5.

Reviews

Carrick S, Ghersi D, Wilcken N, Simes J. Platinum containing regimens for metastatic breast cancer. Cochrane Database of Systematic Reviews 2004; (3): CD003374.

Lord S, Ghersi D, Gattellari M, Wortley S, Wilcken N, Simes J. Antitumour antibiotic containing regimens for metastatic breast cancer. Cochrane Database of Systematic Reviews 2004; (4): CD003367.

Ghersi D, Wilcken N, Simes J, Donoghue E. Taxanes for metastatic breast cancer [Cochrane review]. Cochrane Database of Systematic Reviews 2003; CD003366.

Wilcken N, Hornbuckle J, Ghersi D. Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer [Cochrane review]. Cochrane Database of Systematic Reviews 2003; CD002747.

Wilcken N, Hornbuckle J, Ghersi D. Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer [Cochrane review]. Cochrane Database of Systematic Reviews 2003; CD002747.

Wilcken N. The management of metastatic breast cancer. In Williams C, ed. Evidence-based oncology. London: BMJ Books, 2003.

Wilcken N. Breast cancer screening, IARC report [book review]. The Lancet Oncology 2003, 4: 192–193.

Wilcken N. Treatment of cancer, eds Price and Sikora [book review]. Progress in Palliative Care 2003, March.

Wilcken N. HERA – new lessons from a new trial. Cancer Forum 2003; 27: 8.

Conference presentations & abstracts

2006

Sherman, K., Page, L., Treadgold, C., & Heard, G. (2006). Physical and psychological effects of a structured mixed-type group exercise and support program for breast cancer survivors. International Journal of Behavioral Medicine, 13 Suppl, 345.

Paper presented at the 9^th International Congress of Behavioural Medicine, Bangkok, Thailand.

ISSN: 1070-5503.

Sherman, K., Sheehan, J., Lam, T., & Boyages, J. (2005).  Post-decision regret following breast cancer reconstruction among women with breast cancer.  Breast Cancer Research and Treatment, 94 Supp 1, 273-274.

2005

Orr, N.J., Boyages, S.C. Patterns of care delivery is a stronger predictor of diabetes complications than the late diagnosis of diabetes. 41st Ann Meet Eur Assoc Study Diabetes. 2005. 

Sherman K, Miller S, Glenn M, Rodoletz M, Goldstein L. Knowledge and utilization of lymphoedema risk minimization strategies among breast cancer patients. Add conference details and location February 2005.

Stanwell P, Boyages J, Gluch L, Mountford C. Dynamic contrast-enhanced MR mammography (DCE-MRM) and H-MRS of positive or close margins following breast-conserving surgery. International Society for Magnetic Resonance in Medicine meeting, Miami, Florida, USA, month 2005 (submitted November

2004

Boyages J. The BCI model. (platform) Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Boyages J, Taylor R, Chua B, Ung O, Bilous M, Salisbury E, Wilcken N.  The New South Wales Breast Cancer Institute (BCI) Risk Index for node-negative, T1-T2 breast cancer-comparison with the St Gallen 2001 (SG) Classification.  (poster)  Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Coombs NJ, Boyages J. Surfing the HRT wave in Australia. (poster) Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Coombs NJ, Taylor R, Wilcken N, Boyages J. HRT and breast cancer: a storm in a tea-cup? (platform) Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004.

Coombs NJ, Vassallo PP, Parker AJ, Yiangou C. Radiological review of specimen radiographs after breast Localisation Biopsy is not always necessary. (poster) Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Crossing S, Heard GS, Boyages J. The Directory of Breast Cancer Treatment and Services for NSW Women. (poster) Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004.  

French J. Understanding Surgery. (platform) Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Fuentes H, Heard G, Ung O, Boyages. The NSW Breast Cancer Institute Breast Cancer Information System – a tool for clinical reporting and research. (poster) Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Ghershi D, Henerson IC, Wilcken N, Parker S, Carrick S. (platform) Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004

Ghersi D, Wilcken N, Simes RJ. Taxane-containing regiments for metastatic breast cancer:  a systematic review. (poster) Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Houssami N, Ciatto S. Do radiologists vary in accuracy when reporting mammography according to BI-RADS assessment categories? (poster)  Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Irwig L, Houssami N.  Early detection of breast cancer:  how accurate is breast ultrasound in screening? (poster)  Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Jayasinghe UW, Taylor R, Boyages J.  Is age at diagnosis an independent prognostic factor for survival following breast cancer?  (poster)  Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Jayasinghe UW, Heard GS, O’Connell D, Taylor R, Boyages J.  The management of breast cancer in New South Wales. (poster)  Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Koelmeyer L, Boyages J, Ung O,Taylor R, Jayasinghe U.  Reliability and validity of arm volume measurements for assessment of lymphoedema.  (poster)  Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Koelmeyer L, Lee T. Arm and  shoulder care-improving symptoms following breast cancer treatment. (platform) Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Taylor R, Jayasinghe U, Koelmeyer, Boyages J, Ung O. Reliability and validity of arm volume measurements for assessment of lymphoedema. Add conference details Brisbane, Queensland, March 2004.

Thewes B, Meiser B, Stuart-Harris R, Links M, Wilcken N, MacLachlan SA, Phillips KA, Beith J, Pendlebury S, Boyle F, Baber R, Taylor A, Friedlander ML.  The fertility-and menopause-related information needs of younger women with a diagnosis of early breast cancer. Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004.

Thewes B, Meiser B, Duric V, Stockler M, Stuart-Harris R, Links M, Wilcken N, MacLachlan SA, Phillips KA, Beith J, Pendlebury S, Boyle F, Baber R, Taylor A, Friedlander ML. What survival benefits do pre-menopausal early breast cancer patients consider necessary to make endocrine thereapy worthwhile?. (platform) Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Ung O. Advanced surgical techniques. (platform) Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Ung O. Surgery – back to the future. (platform) Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Wilcken N, Boyages J, Taylor R.  Estimating the effects of adjuvant systemic therapy on survival in node-negative breast cancer.  (poster)  Presented at the Leura V International Breast Cancer Conference, Sydney, Australia 10-14 November 2004. 

Wilcken N. Breast cancer treatment 2000–2020. The 2004 Amgen Clinical Pharmacy Symposium, Sydney, 23 & 24 October 2004

2003

Crossing S, Heard G, Boyages J. Finding a specialist: the Directory of breast cancer treatment and services for NSW women. COSA, Perth, November 2003.

Wilcken N. Evidence-based guidelines: chemotherapy versus endocrine therapy for metastatic breast cancer. Central European Cooperative Oncology Group, Vienna, Austria, January.

2002

Ahern V. Live radiotherapy demonstation. Westmead Association Hospital Week: Breast Cancer Symposium, Westmead, August 2002.

Boyages J. Delivering multidisciplinary care. Westmead Association Hospital Week: Breast Cancer Symposium, Westmead, August 2002.

Boyages J, Cooper M. Radiotherapy issues. Westmead Association Hospital Week: Breast Cancer Symposium, Westmead, August 2002.

Hughes M, Moon D. Surgical issues. Westmead Association Hospital Week: Breast Cancer Symposium, Westmead, August 2002.

Leong C, Boyages J, Bilous M,    . The effect of margins on i[silateral breast tumour recurrence after breast conservation therapy for node-negative breast cancer. Breast Cancer Research and Treatment 2002; 76: 448 Suppl. 1.

Ung O, French J. Live surgical demonstration. Westmead Association Hospital Week: Breast Cancer Symposium, Westmead, August 2002.

Wilcken N. Chemotherapy issues. Westmead Association Hospital Week: Breast Cancer Symposium, Westmead, August 2002.

2001

Tan M, Lam T, Sandelin K, Taylor R, Ung O. Immediate breast reconstruction as an integrated approach in a state cancer institute. 13th Biennial Congress of the Asian Surgical Association, Singapore, November 2001.

Tan M, Lam T, Sandelin K, Taylor R, Ung O. Immediate breast reconstruction as an integrated option – a pilot study. Australian and New Zealand Journal of Surgery, Add conference details and location (conference abstract was published in the journal), 2001.

2000

Boyages J, Chua B, Taylor R, et al. The St. Gallen Classification for patients with node-negative breast cancer is an insensitive measure of Prognosis. Presented at the 4th Leura International Breast Cancer Conference, Blue Mountains, November 2000.

Boyages J, Heard G, Ung O, et al. What women want from a multidisciplinary breast cancer centre: the New South Wales (NSW) Breast Cancer Institute’s Westmead Breast Centre. Presented at the 4th Leura International Breast Cancer Conference, Blue Mountains, November 2000.

Chua B, Davis P, Boyages J. Integrated information management in a multidisciplinary breast centre. Presented at the 4th Leura International Breast Cancer Conference, Blue Mountains, November 2000.

Chua B, Ung OA, Boyages J. Competing considerations in regional nodal treatment for early breast cancer. Presented at the 4th Leura International Breast Cancer Conference, Blue Mountains, November 2000.

Chua B, Ung O, Boyages J. Towards optimal treatment of the axilla in early breast cancer. Poster p resented at the 36th Annual Meeting of the American Society of Clinical Oncology, New Orleans, Louisiana, May.

Chua B, Ung O, Boyages J. Treatment of the axilla in early breast cancer: past, present and future. Presented at the 4th Leura International Breast Cancer Conference, Blue Mountains, November 2000.

Chua B, Ung O, Taylor R, Boyages J. Frequency and predictors of axillary lymph node metastases in early breast cancer. Presented at the 4th Leura International Breast Cancer Conference, Blue Mountains, November 2000.

Chua B, Ung O, Taylor R, et al. Is there a role for axillary clearance in patients with operable breast cancer in the era of conservation? Presented at the 4th Leura International Breast Cancer Conference, Blue Mountains, November 2000.

Chua B, Ung O, Taylor R, et al. Treatment implications of a positive sentinel lymph node biopsy in early breast cancer. Presented at the 4th Leura International Breast Cancer Conference, Blue Mountains, November 2000.

De Morgan S, White K, Boyages J, Chakir B. Well doc, have I got cancer or haven’t I? Providing information in situations of confusion. Presented at the COSA Meeting, Sydney, October.

Green J, Koelmeyer L, Lazarus S, Lee B, O’Brien L, Shanley K, Smith B. A support program for people living with Lymphoedema: a pilot project [contributed platform presentation]. Australian Lymphology Society Meeting, Melbourne, April.

Koelmeyer L. Living with lymphoedema: evaluation of a pilot project [abstract]. NSW Occupational Therapists Conference, Sydney, May.

Koelmeyer L, O’Brien L, Shanley K [for the Lymphoedema Support Group of NSW at Mt Wilga Private Hospital, St George Hospital and Westmead Hospital]. Lymphoedema: grading the diagnosis—does current grading give the full picture? [contributed poster]. Australian Lymphology Society Meeting, Melbourne, April.

Moon D, Ung O, Stephens D, et al. Advanced Breast Biopsy Instrumentation ( ABBI): results from Westmead Hospital. Presented at the Royal Australasian College of Surgeons’ Annual scientific Congress, Melbourne, May.

Stephens D, Ung O, Bilous M, et al. Advanced Breast Biopsy Instrumentation (ABBI): results from Westmead Hospital. Presented at the Royal Australasian College of Radiologists’ Meeting, Auckland, October.

Taylor R, Boyages J. Absolute risk of breast cancer for Australian women with a family history. Presented at the 4th Leura International Breast Cancer Conference, Blue Mountains, November 2000.

Taylor R, Davis P, Boyages J. Long-term survival with breast cancer: New South Wales women. Presented at the 4th Leura International Breast Cancer Conference, Blue Mountains, November 2000.

Ung O. Future management of breast cancer: the sentinel node debate. Presented at the 3rd Australasian Lymphology Association Conference, Melbourne, April.

Ung O, Lee W, Greenberg M, Bilous M. Complex sclerosing lesion: the lesion is complex, the management is straightforward. Presented at the 4th Leura International Breast Cancer Conference, Blue Mountains, November 2000.

Ung OA, Stephens D, Bilous M, et al. Advanced Breast Biopsy Instrumentation (ABBI): results from Westmead Hospital. Presented at the 4th Leura International Breast Cancer Conference, Blue Mountains, November 2000.

1999

*Boyages J. The role of radiotherapy in the management of DCIS subtypes [invited presentation]. Presented at Mammography Education 1999, Hamilton Island, Queensland, October, 1999.

*Boyages J. The role of radiotherapy in the management of early stage, invasive breast cancer. [invited presentation]. Presented at Mammography Education 1999, Hamilton Island, Queensland, October, 1999.

*Boyages J. The role of radiotherapy in the management of early stage, invasive breast cancer, special forms [invited presentation]. Presented at Mammography Education 1999, Hamilton Island, Queensland, October, 1999.

*Ung OA. Diagnosis and removal of screen-detected breast lesions—large core. [invited abstract and presentation] Proceedings of the 2nd Annual Meeting of the Australian Society of Breast Disease, Gold Coast, Queensland, September, 1999.

*Chua B, Ung OA, Boyages J. Treatment of the axilla—past, present and future. [contributed abstract] Presented at the Annual Meeting of the Royal Australasian College of Radiologists, Brisbane, October 1999.

1998

Boyages J. Future directions for breast cancer care. Proceedings of the 27th Annual Scientific Meeting of the NZ Society of Oncology, Christchurch, May 1998.

Boyages J. Ductal carcinoma in situ (DCIS)—dilemmas in management. Proceedings of the 27th Annual Scientific Meeting of the NZ Society of Oncology, Christchurch, May 1998.

*Francis M, Cakir B, Bilous M, Ung O, Boyages J. Infiltrating lobular carcinoma: Is breast conservation possible? Presented to the inaugural meeting of the Australiasian Society for Breast Disease, Gold Coast, Queensland, September, 1998

*Humphrey K [on behalf of the Tumour Bank Steering Committee: Bilous M (Director), Balleine R, Boyages J, Clarke C, Humphrey K, Newman P, Salisbury E, Ung O]. Current challenges for the establishment of a breast tumour bank. A poster for the 1st meeting of the Victorian Breast Cancer Research Consortium, New Horizons in Breast Cancer Research, Melbourne, November 16–18, 1998

*Mukherjee RK, Ahern V, Boyages J, Gano C, Langlands AO. Locally advanced breast cancer—a role for mastectomy? Royal Australasian College of Radiologists meeting, Brisbane, October 1998.

*Nguyen H, Hung WT, Thornton BS, Thornton E, Lee W. Classification of microcalcifications in mammograms using artificial neural networks. Proceedings of the 20th International Conference of the IEEE on Engineering in Medicine and Biology, Hong Kong, October/November 1998.

*Rangan A. Local recurrence after mastectomy and adjuvant chemotherapy: implications for adjuvant radiation therapy. Presented to the inaugural meeting of the Australiasian Society for Breast Disease, Gold Coast, Queensland, September, 1998

1997

Beller E, Brassil A, Anura P, Parr N, Taylor R, Apostolopoulos P, Stubbs J, Boyages J. Projections of mammographic screens in NSW women. BreastScreen Australia Conference, Canberra, August 1997.

Boyages, J. Why screen for breast cancer? Proc National Workshop for mammographic screening. Ottawa, Canada, April 1997

Boyages, J. The diagnostic process. Proc National Workshop for mammaographic screening. Ottawa, Canada, April 1997

Newman P, Bilous AM, Anura P, Boyages J. Quality review of histopathology in a breast cancer screening program. American Society of Cliical Oncoogyl. 16:416a, 1997. Abstract.

Newman P, Bilous AM, Anura P, Boyages J. Quality review of histopathology in a breast cancer screening program. BreastScreen Australia Conference, Canberra, August 1997.

Newman P. Histopathological diagnosis: Inter- and intra-observer variation. Paper presentation. NSW Breast Cancer Institute International Pathology Workshop, Sydney, July 1997.

Newman P. Histopathological diagnosis: inter-observer variation. Paper presentation. BreastScreen Australia Conference, Canberra, August 1997.

Sardelic F, Stubbs J, Newman P, Anura P, Boyages J. Assessment and surgery for benign breast conditions identified in a mammographic screening programme. Paper presentation. BreastScreen Australia Conference, Canberra, August 1997.

Stubbs J, Newman P, Sardelic F, Boyages J. Morbidity associated with surgery for benign screen detected mammographic lesions. BreastScreen Australia Conference, Canberra, August 1997.

Stubbs J, Boyages J. Evolution of a system for routinely collecting outcome data for patients with breast cancer. American Soc. Clin. Oncol. 16:427a, 1997. Abstract.

1996

Newman P, Langlands AO, Anura P, Salama T, Boyages J. Evaluation of a breast cancer reskilling program for general practitioners. Third Leura International Breast Cancer Conference, Leura, November 1996.

Papadatos G, Rangan A, Boyages J. Tubular carcinoma of the breast. Third Leura International Breast Cancer Conference, Leura, November 1996.

Sardelic F, Newman P, Stubbs J, Boyages J. Assessment and surgery for benign conditions identified in a mammographic screening program. Third Leura International Breast Cancer Conference, Leura, November 1996.

Stubbs J, Taylor R, Anura P, Bilous M, Bonar F, Cregan P, Langlands A, Leeder S, Boyages J. Breast cancer patterns of care in Western Sydney in 1992. Third Leura International Breast Cancer Conference, Leura, November 1996.

Wong S, Rangan A, Bilous M, Boyages J, Langlands AO, Benson E. The value of S phase and DNA ploidy analysis as prognostic markers for node negative breast cancer in the Australian setting. Third Leura International Breast Cancer Conference, Leura, November 1996.

Last Updated on Wednesday, 16 June 2010 07:35